Contemporary medicine is founded on independent measurement but following psychological wellbeing has been restricted to particular information in a medical surrounding. The Principal to Mindstrong Health, Paul Dagum, thinks that to improve the outcome for individuals with the mental disorder, one might require objective measures for other prolonged diseases. The technology at Mindstrong provides an incessant, unbiased measures of performance and understanding at a resolution level. There is now a platform where the scrolling and typing on a digital phone can be used to determine the brain functioning of the patient. Jim Tananbaum, who is the Principal of Foresite Capital, said in the release that the team of Mindstrong Health enlightens ways in which medical community cares for patients suffering from cognitive health orders.
The aim of Mindstrong is to provide patients with the incessant numerical biomarkers of attitude and cognition which is inclusive of speed care, memory, and executive purpose. The smartphones are the best shot in finding a solution to the mental disorders using this special technology. Jim states that by combining various technologies and leadership from Paul, Rick, and Tom, there is a chance that the outcomes will get a stage that updates and greatly improves the method of care providence. Visit Crunchbase to know more.
Jim Tananbaum is the initiator and Principal of Foresite Capital. Besides Foresite Capital, he is a co-founder of Prospect Venture Partner and Theravance. Mr. Tananbaum has an MBA, an MD from Harvard Business School, and Harvard Medical School respectively. He also has a B.S in electrical engineering from Yale University. His 25 years’ experience has seen him through very many investments that have strategically placed him in the top 100 Forbes list investors. He is a man focused on strategic, operational and financial opportunities to assist in franchising healthcare enterprises. Foresite Capital seeks to provide capital to upcoming healthcare frontrunners who have disruptive produces and services across most healthcare segments. Foresite is currently based in San Francisco and offices in New York. He is also a co-partner at GelTex Pharmaceuticals a drug manufacturing company that brought two drugs to the market earning them almost $1.6 billion.